| Drug repurposing against key COVID-19 drug targets using advance machine learning-based algorithms | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Development of a portable optical cavity sterilisation unit | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Structural, biochemical and computational investigation on the therapeutic targets of SARS-CoV-2 and structure-based drug discovery from Indian herbs | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Understanding the role of SARS-CoV-2 virulence factor-Orf3a in modulating host cell responses: A way to identify host-directed therapy | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Targeting the RNA-dependent RNA polymerase (RdRp) of SARS-CoV-2 for the development of inhibitors | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Development of a point-of-care fibre-optic biosensor (P-FAB) device for rapid detection of COVID-19 | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| An easy and rapid detection platform for viral diseases from saliva: COVID-19 and beyond | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Development of machine learning-based drug repurposing pipeline against SARS-CoV-2 and human proteome | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| Rapid, PCR or antibody-free clinical diagnosis of viral infection via ‘chemical-nose’ sensor | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |
| A phase II B open label randomised controlled trial to evaluate the efficacy and safety of Ivermectin in reducing viral loads in patients with hematological disorders who are admitted with COVID-19 infection (ICE study) | COVID-19 Research, Life Sciences & Biotechnology | 2020 | |